Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01768065 · ClinicalTrials.gov registry record · Early Phase 1
Nasal Expiratory Positive Airway Pressure for the Treatment of Pediatric Obstructive Sleep Apnea Syndrome
A Early Phase 1 study, sponsored by Children's Hospital of Philadelphia.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 15
- Enrollment target
NCT01768065 is a Early Phase 1 study that has completed, run by Children's Hospital of Philadelphia. The registered enrollment target is 15 participants.
The verdict
NCT01768065, a Early Phase 1 study, has completed, sponsored by Children's Hospital of Philadelphia.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 15 participants
- Enrollment target
Study Summary
This study will evaluate effectiveness and adherence of the nasal expiratory positive airway pressure (NEPAP) device as an an alternate therapy for children with Obstructive Sleep Apnea Syndrome (OSAS). NEPAP is currently approved for use only in adults.
Interventions
- DEVICE Nasal Expiratory Positive Airway Pressure Device
- DEVICE placebo sham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2012-07 |
| Est. Completion | 2013-04 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01768065
The ClinicalTrials.gov registry entry for NCT01768065 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Hospital of Philadelphia, which has 431 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Nasal Expiratory Positive Airway Pressure Device is the first listed.
NCT01768065 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01768065 about?
NCT01768065 is a clinical study titled "Nasal Expiratory Positive Airway Pressure for the Treatment of Pediatric Obstructive Sleep Apnea Syndrome". This study will evaluate effectiveness and adherence of the nasal expiratory positive airway pressure (NEPAP) device as an an alternate therapy for children with Obstructive Sleep Apnea Syndrome (OSAS). NEPAP is currently approved for use only in adults.
What is the current status of trial NCT01768065?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 15 participants. The study started on 2012-07. Estimated completion is 2013-04.
What interventions are being tested in trial NCT01768065?
The interventions under investigation include: Nasal Expiratory Positive Airway Pressure Device (DEVICE), placebo sham (DEVICE).
Who is sponsoring clinical trial NCT01768065?
This trial is sponsored by Children's Hospital of Philadelphia, which has 431 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.